 | • レポートコード：QYR9N7135 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、自律神経失調症のグローバル市場について調査・分析したレポートで、種類別（原発性自律神経失調症、続発性自律神経失調症）、用途別（病院と診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・自律神経失調症の世界市場規模 ・主要企業別市場シェア ・自律神経失調症の世界市場規模：種類別（原発性自律神経失調症、続発性自律神経失調症） ・自律神経失調症の世界市場規模：用途別（病院と診療所、その他） ・自律神経失調症のアメリカ市場規模（種類別、用途別） ・自律神経失調症のヨーロッパ市場規模（種類別、用途別） ・自律神経失調症の中国市場規模（種類別、用途別） ・自律神経失調症の日本市場規模（種類別、用途別） ・自律神経失調症の東南アジア市場規模（種類別、用途別） ・自律神経失調症のインド市場規模（種類別、用途別） ・自律神経失調症の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・自律神経失調症の世界市場予測（2019年-2025年） ・自律神経失調症の地域別市場予測（2019年-2025年） ... |
Dysautonomia (Autonomic Dysfunction) is a disorder of autonomic nervous system.Factors driving global demand for Dysautonomia are increasing awareness amongst people, government initiatives and increased diagnosis.
In 2018, the global Dysautonomia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Dysautonomia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dysautonomia development in United States, Europe and China.
The key players covered in this study
Novartis
Pfizer
Celltex Therpeutics
Shire
Santhera Pharmaceuticals
Theravance Biopharma
Lundbeck
Axsome Therpeutics
Merck
Market segment by Type, the product can be split into
Primary Dysautonomia
Secondary Dysautonomia
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Dysautonomia status, future forecast, growth opportunity, key market and key players.
To present the Dysautonomia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Dysautonomia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dysautonomia Market Size Growth Rate by Type (2014-2025)
1.4.2 Primary Dysautonomia
1.4.3 Secondary Dysautonomia
1.5 Market by Application
1.5.1 Global Dysautonomia Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Dysautonomia Market Size
2.2 Dysautonomia Growth Trends by Regions
2.2.1 Dysautonomia Market Size by Regions (2014-2025)
2.2.2 Dysautonomia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Dysautonomia Market Size by Manufacturers
3.1.1 Global Dysautonomia Revenue by Manufacturers (2014-2019)
3.1.2 Global Dysautonomia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dysautonomia Market Concentration Ratio (CR5 and HHI)
3.2 Dysautonomia Key Players Head office and Area Served
3.3 Key Players Dysautonomia Product/Solution/Service
3.4 Date of Enter into Dysautonomia Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Dysautonomia Market Size by Type (2014-2019)
4.2 Global Dysautonomia Market Size by Application (2014-2019)
5 United States
5.1 United States Dysautonomia Market Size (2014-2019)
5.2 Dysautonomia Key Players in United States
5.3 United States Dysautonomia Market Size by Type
5.4 United States Dysautonomia Market Size by Application
6 Europe
6.1 Europe Dysautonomia Market Size (2014-2019)
6.2 Dysautonomia Key Players in Europe
6.3 Europe Dysautonomia Market Size by Type
6.4 Europe Dysautonomia Market Size by Application
7 China
7.1 China Dysautonomia Market Size (2014-2019)
7.2 Dysautonomia Key Players in China
7.3 China Dysautonomia Market Size by Type
7.4 China Dysautonomia Market Size by Application
8 Japan
8.1 Japan Dysautonomia Market Size (2014-2019)
8.2 Dysautonomia Key Players in Japan
8.3 Japan Dysautonomia Market Size by Type
8.4 Japan Dysautonomia Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Dysautonomia Market Size (2014-2019)
9.2 Dysautonomia Key Players in Southeast Asia
9.3 Southeast Asia Dysautonomia Market Size by Type
9.4 Southeast Asia Dysautonomia Market Size by Application
10 India
10.1 India Dysautonomia Market Size (2014-2019)
10.2 Dysautonomia Key Players in India
10.3 India Dysautonomia Market Size by Type
10.4 India Dysautonomia Market Size by Application
11 Central & South America
11.1 Central & South America Dysautonomia Market Size (2014-2019)
11.2 Dysautonomia Key Players in Central & South America
11.3 Central & South America Dysautonomia Market Size by Type
11.4 Central & South America Dysautonomia Market Size by Application
12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dysautonomia Introduction
12.1.4 Novartis Revenue in Dysautonomia Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dysautonomia Introduction
12.2.4 Pfizer Revenue in Dysautonomia Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Celltex Therpeutics
12.3.1 Celltex Therpeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dysautonomia Introduction
12.3.4 Celltex Therpeutics Revenue in Dysautonomia Business (2014-2019)
12.3.5 Celltex Therpeutics Recent Development
12.4 Shire
12.4.1 Shire Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dysautonomia Introduction
12.4.4 Shire Revenue in Dysautonomia Business (2014-2019)
12.4.5 Shire Recent Development
12.5 Santhera Pharmaceuticals
12.5.1 Santhera Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dysautonomia Introduction
12.5.4 Santhera Pharmaceuticals Revenue in Dysautonomia Business (2014-2019)
12.5.5 Santhera Pharmaceuticals Recent Development
12.6 Theravance Biopharma
12.6.1 Theravance Biopharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dysautonomia Introduction
12.6.4 Theravance Biopharma Revenue in Dysautonomia Business (2014-2019)
12.6.5 Theravance Biopharma Recent Development
12.7 Lundbeck
12.7.1 Lundbeck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dysautonomia Introduction
12.7.4 Lundbeck Revenue in Dysautonomia Business (2014-2019)
12.7.5 Lundbeck Recent Development
12.8 Axsome Therpeutics
12.8.1 Axsome Therpeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dysautonomia Introduction
12.8.4 Axsome Therpeutics Revenue in Dysautonomia Business (2014-2019)
12.8.5 Axsome Therpeutics Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dysautonomia Introduction
12.9.4 Merck Revenue in Dysautonomia Business (2014-2019)
12.9.5 Merck Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Dysautonomia Key Market Segments
Table Key Players Dysautonomia Covered
Table Global Dysautonomia Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Dysautonomia Market Size Market Share by Type 2014-2025
Figure Primary Dysautonomia Figures
Table Key Players of Primary Dysautonomia
Figure Secondary Dysautonomia Figures
Table Key Players of Secondary Dysautonomia
Table Global Dysautonomia Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Others Case Studies
Figure Dysautonomia Report Years Considered
Table Global Dysautonomia Market Size 2014-2025 (Million US$)
Figure Global Dysautonomia Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dysautonomia Market Size by Regions 2014-2025 (Million US$)
Table Global Dysautonomia Market Size by Regions 2014-2019 (Million US$)
Table Global Dysautonomia Market Share by Regions 2014-2019
Figure Global Dysautonomia Market Share by Regions 2014-2019
Figure Global Dysautonomia Market Share by Regions 2019
Table Market Top Trends
Table Global Dysautonomia Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Dysautonomia Market Share by Manufacturers (2014-2019)
Figure Global Dysautonomia Market Share by Manufacturers in 2018
Table Global Dysautonomia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dysautonomia Product/Solution/Service
Table Date of Enter into Dysautonomia Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dysautonomia Market Size by Type (2014-2019) (Million US$)
Table Global Dysautonomia Market Size Share by Type (2014-2019)
Figure Global Dysautonomia Market Size Market Share by Type (2014-2019)
Table Global Dysautonomia Market Size by Application (2014-2019) (Million US$)
Table Global Dysautonomia Market Size Share by Application (2014-2019)
Figure Global Dysautonomia Market Size Market Share by Application (2014-2019)
Figure Global Dysautonomia Revenue Market Share by Application in 2018
Figure United States Dysautonomia Market Size 2014-2019 (Million US$)
Table United States Key Players Dysautonomia Revenue (2018-2019) (Million US$)
Table United States Key Players Dysautonomia Market Share (2018-2019)
Table United States Dysautonomia Market Size by Type (2014-2019) (Million US$)
Table United States Dysautonomia Market Share by Type (2014-2019)
Table United States Dysautonomia Market Size by Application (2014-2019) (Million US$)
Table United States Dysautonomia Market Share by Application (2014-2019)
Figure Europe Dysautonomia Market Size 2014-2019 (Million US$)
Table Europe Key Players Dysautonomia Revenue (2018-2019) (Million US$)
Table Europe Key Players Dysautonomia Market Share (2018-2019)
Table Europe Dysautonomia Market Size by Type (2014-2019) (Million US$)
Table Europe Dysautonomia Market Share by Type (2014-2019)
Table Europe Dysautonomia Market Size by Application (2014-2019) (Million US$)
Table Europe Dysautonomia Market Share by Application (2014-2019)
Figure China Dysautonomia Market Size 2014-2019 (Million US$)
Table China Key Players Dysautonomia Revenue (2018-2019) (Million US$)
Table China Key Players Dysautonomia Market Share (2018-2019)
Table China Dysautonomia Market Size by Type (2014-20189) (Million US$)
Table China Dysautonomia Market Share by Type (2014-2019)
Table China Dysautonomia Market Size by Application (2014-2019) (Million US$)
Table China Dysautonomia Market Share by Application (2014-2019)
Figure Japan Dysautonomia Market Size 2014-2019 (Million US$)
Table Japan Key Players Dysautonomia Revenue (2018-2019) (Million US$)
Table Japan Key Players Dysautonomia Market Share (2018-2019)
Table Japan Dysautonomia Market Size by Type (2014-2019) (Million US$)
Table Japan Dysautonomia Market Share by Type (2014-2019)
Table Japan Dysautonomia Market Size by Application (2014-2019) (Million US$)
Table Japan Dysautonomia Market Share by Application (2014-2019)
Figure Southeast Asia Dysautonomia Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dysautonomia Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dysautonomia Market Share (2018-2019)
Table Southeast Asia Dysautonomia Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Dysautonomia Market Share by Type (2014-2019)
Table Southeast Asia Dysautonomia Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Dysautonomia Market Share by Application (2014-2019)
Figure India Dysautonomia Market Size 2014-2019 (Million US$)
Table India Key Players Dysautonomia Revenue (2018-2019) (Million US$)
Table India Key Players Dysautonomia Market Share (2018-2019)
Table India Dysautonomia Market Size by Type (2014-2019) (Million US$)
Table India Dysautonomia Market Share by Type (2014-2019)
Table India Dysautonomia Market Size by Application (2014-2019) (Million US$)
Table India Dysautonomia Market Share by Application (2014-2019)
Figure Central & South America Dysautonomia Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dysautonomia Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dysautonomia Market Share (2018-2019)
Table Central & South America Dysautonomia Market Size by Type (2014-2019) (Million US$)
Table Central & South America Dysautonomia Market Share by Type (2014-2019)
Table Central & South America Dysautonomia Market Size by Application (2014-2019) (Million US$)
Table Central & South America Dysautonomia Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Dysautonomia Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Dysautonomia Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Dysautonomia Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Dysautonomia Business (2014-2019)
Table Pfizer Recent Development
Table Celltex Therpeutics Company Details
Table Celltex Therpeutics Revenue in Dysautonomia Business (2014-2019)(Million US$)
Figure Celltex Therpeutics Revenue Growth Rate in Dysautonomia Business (2014-2019)
Table Celltex Therpeutics Recent Development
Table Shire Company Details
Table Shire Revenue in Dysautonomia Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Dysautonomia Business (2014-2019)
Table Shire Recent Development
Table Santhera Pharmaceuticals Company Details
Table Santhera Pharmaceuticals Revenue in Dysautonomia Business (2014-2019)(Million US$)
Figure Santhera Pharmaceuticals Revenue Growth Rate in Dysautonomia Business (2014-2019)
Table Santhera Pharmaceuticals Recent Development
Table Theravance Biopharma Company Details
Table Theravance Biopharma Revenue in Dysautonomia Business (2014-2019)(Million US$)
Figure Theravance Biopharma Revenue Growth Rate in Dysautonomia Business (2014-2019)
Table Theravance Biopharma Recent Development
Table Lundbeck Company Details
Table Lundbeck Revenue in Dysautonomia Business (2014-2019)(Million US$)
Figure Lundbeck Revenue Growth Rate in Dysautonomia Business (2014-2019)
Table Lundbeck Recent Development
Table Axsome Therpeutics Company Details
Table Axsome Therpeutics Revenue in Dysautonomia Business (2014-2019)(Million US$)
Figure Axsome Therpeutics Revenue Growth Rate in Dysautonomia Business (2014-2019)
Table Axsome Therpeutics Recent Development
Table Merck Company Details
Table Merck Revenue in Dysautonomia Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Dysautonomia Business (2014-2019)
Table Merck Recent Development
Table Global Dysautonomia Market Size by Regions (Million US$) 2019-2025
Figure Global Dysautonomia Market Size Share by Regions (2019-2025)
Figure Global Dysautonomia Market Size Share by Regions in 2025
Figure United States Dysautonomia Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dysautonomia Market Size Forecast (2019-2025)(Million USD)
Figure China Dysautonomia Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dysautonomia Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dysautonomia Market Size Forecast (2019-2025)(Million USD)
Figure India Dysautonomia Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dysautonomia Market Size Forecast (2019-2025)(Million USD)
Table Global Dysautonomia Market Size by Product (2019-2025) (Million US$)
Figure Global Dysautonomia Market Size by Product (2019-2025)
Figure Global Dysautonomia Market Size by Product in 2025
Table Global Dysautonomia Market Size by Application (2019-2025) (Million US$)
Figure Global Dysautonomia Market Size by Application (2019-2025)
Figure Global Dysautonomia Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の病院市場：市場規模・現状・予測 A hospital is a health care institution providing patient treatment with specialized medical and nursing staff and medical equipment.In 2018, the global Hospitals market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This r…- 世界のマイクロ病院市場：市場規模・現状・予測 Micro-hospitals are small-scale inpatient facilities on two to three-story buildings built on 20,000 to 50,000-square foot spaces that offer a wide range of medical services in a small, neighborhood setting. They run 24/7, all year long, and commonly have between eight and 10 beds where patients can…
- 世界の外来診療所市場：市場規模・現状・予測 The outpatient clinics has continued to play a significant role in management of the cognitive behavioral disorders. High-risk situations such as substance abuse, sexual offence, depression, obesity and obsessive-compulsive behavior is becoming a major concern in various countries. Management of hig…
- 世界の腫瘍治療フィールド（TTFields）市場：市場規模・現状・予測 Tumor Treating Field (TTField) is an anticancer treatment which disrupts the tumor cells mitosis. Tumor Treating Field is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer.North America is projected to hold largest…
- 世界のサルコペニア治療市場：市場規模・現状・予測 Sarcopenia is the degenerative loss of skeletal muscle mass (0.5-1% loss per year after the age of 50), quality and strength associated with aging.Sarcopenia is characterized first by a muscle atrophy, along with a reduction in muscle tissue quality, characterized by such factors as replacement of m…